Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_assertion type Assertion NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_head.
- NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_assertion description "[VIP (Vasoactive intestinal peptide) expression was decreased in Rhematoid Arthritis (RA) synovial fibroblasts (FLS) compared with Osteoarthritis (OA) FLS; in RA FLS, VPAC2 (VIP receptor type 2) mediates the antiinflammatory effects of VIP ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_provenance.
- NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_assertion evidence source_evidence_literature NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_provenance.
- NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_assertion SIO_000772 18383383 NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_provenance.
- NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_assertion wasDerivedFrom lhgdn-20090331 NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_provenance.
- NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_assertion wasGeneratedBy ECO_0000203 NP129948.RAAqLq9z-pLlMYKSJdIWACkzM8gSrcpPMGSYLJkYcPJlU130_provenance.